|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation expense | |||||
| Stock-based compensation expense | |||||
| Noncash lease expense | |||||
| Noncash interest and other expense, net | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Interest payable | |||||
| Operating lease liabilities | |||||
| Cash used in operating activities | |||||
| Investing activities: | |||||
| Purchase of property and equipment | |||||
| Cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from the issuance of common stock, net of issuance costs | |||||
| Proceeds from the issuance of pre-funded warrants, net of issuance costs | |||||
| Proceeds from the issuance of common stock warrants, net of issuance costs | |||||
| Proceeds from the issuance of common stock under equity plan awards | |||||
| Cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for business taxes | |||||
| Non-cash investing activities: | |||||
| Property and equipment in accounts payable | |||||
Loading...